Reckitt Benckiser Group (RKT)

Sector:

Household Goods

Index:

FTSE 100

5,716.00p
   
  • Change Today:
      32.00p
  • 52 Week High: 5,788.00p
  • 52 Week Low: 4,514.00p
  • Currency: UK Pounds
  • Shares Issued: 676.41m
  • Volume: 612,289
  • Market Cap: £38,664m

Reckitt said to have started talks on £6bn sale of homecare assets

By Michele Maatouk

Date: Wednesday 18 Sep 2024

LONDON (ShareCast) - (Sharecast News) - Reckitt Benckiser has reportedly started early discussions with some of the potential suitors for its homecare assets, which could fetch more than £6bn in a deal.
Bloomberg cited people familiar with the matter as saying that the consumer goods giant is working with Morgan Stanley for the brands including air freshener Airwick and Cillit Bang cleaners.

Mostly financial investors as well as some consumer companies have shown interest in the assets, the sources said, adding that a formal sale process is likely to kick off within months and be completed in 2025.

It was also understood that Goldman Sachs is helping Reckitt on evaluating options for its formula brand Mead Johnson, including a potential sale. Deliberations are ongoing and no final decision has been made, the people said.

Reckitt announced in July that it was planning to sell some of the homecare brands that it's deemed non-core and review options for its infant formula business. It said it wanted to focus on "power brands" like Strepsils lozenges, the Mucinex cold remedy, Gaviscon for heartburn and Durex condoms, along with some disinfectants like Harpic, Vanish, Dettol and Lysol that boomed during the pandemic.



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Reckitt Benckiser Market Data

Currency UK Pounds
Share Price 5,716.00p
Change Today 32.00p
% Change 0.56 %
52 Week High 5,788.00p
52 Week Low 4,514.00p
Volume 612,289
Shares Issued 676.41m
Market Cap £38,664m

Reckitt Benckiser Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.85% below the market average85.85% below the market average85.85% below the market average85.85% below the market average85.85% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
38.50% above the market average38.50% above the market average38.50% above the market average38.50% above the market average38.50% above the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average
Income
26.26% above the market average26.26% above the market average26.26% above the market average26.26% above the market average26.26% above the market average
22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average
Growth
10.62% below the market average10.62% below the market average10.62% below the market average10.62% below the market average10.62% below the market average
54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average

What The Brokers Say

Strong Buy 4
Buy 6
Neutral 8
Sell 0
Strong Sell 0
Total 18
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Reckitt Benckiser Dividends

  Latest Previous
  Interim Final
Ex-Div 07-Aug-25 10-Apr-25
Paid 18-Sep-25 29-May-25
Amount 84.40p 121.70p

Trades for 19-Sep-2025

Time Volume / Share Price
14:37 47 @ 5,716.00p
14:37 11 @ 5,716.00p
14:37 60 @ 5,716.00p
14:37 41 @ 5,714.00p
14:37 69 @ 5,714.00p

Reckitt Benckiser Key Personnel

Chair Jeremy Darroch
CEO Kris Licht

Top of Page